Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Nutrition (Burbank, Los Angeles County, Calif.)|March 18, 2018
Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolizationRyu Sasaki, Naota Taura, Yuri Miyazoe, et al.
International Journal of Clinical Oncology|July 16, 2020
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective studyShintaro Nakano, Satoshi Yuki, Yasuyuki Kawamoto, et al.
The American Journal of Case Reports|July 5, 2013
Two difficulty diagnosis cases of severe veno-occlusive diseaseHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.
Scientific Reports|January 29, 2021
Src-mediated tyrosine phosphorylation of PRC1 and kinastrin/SKAP on the mitotic spindleMariko Morii, Sho Kubota, Chizu Hasegawa, et al.
Experimental and Therapeutic Medicine|December 11, 2012
Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosisNaota Taura, Sachiko Fukuda, Tatsuki Ichikawa, et al.
Global Health & Medicine|September 17, 2021
A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancerTakayuki Oishi, Yuka Sasaki, Ying Tong, et al.
BMC Cancer|January 4, 2022
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)Taro Shibuki, Toshihiko Mizuta, Mototsugu Shimokawa, et al.
International Journal of Clinical Oncology|May 20, 2023
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON studyAzusa Komori, Satoshi Otsu, Mototsugu Shimokawa, et al.
Translational Oncology|March 19, 2026
Genomic landscape of pleural mesothelioma in Japanese patients: A comprehensive analysis using nationwide databaseHirokazu Taniguchi, Kazumasa Akagi, Takahito Fukuda, et al.
Anticancer Research|March 28, 2023
Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxelYasushi Ide, Taiga Otsuka, Mototsugu Shimokawa, et al.
Pageof 12